Oral antiallergic activity in ascaris hypersensitive dogs: A study of known antihistamines and of the new compounds ramastine (R 57 959) and levocabastine (R 50 547)
- 1 May 1986
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 8 (1-4) , 95-102
- https://doi.org/10.1002/ddr.430080112
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Levocabastine (R 50547): The prototype of a chemical series of compounds with specific H1‐antihistaminic activityDrug Development Research, 1986
- Effects of serum albumin, indomethacin and histamine H1‐antagonists on Paf‐acether‐induced inflammatory responses in the skin of experimental animals and manBritish Journal of Pharmacology, 1985
- Further studies on the distinctive sleep‐wakefulness profiles of antihistamines (astemizole, ketotifen, terfenadine) in dogsDrug Development Research, 1983
- The in vivo pharmacological profile of histamine (H1) antagonists in the ratDrug Development Research, 1982
- PROTECTION OF RATS FROM COMPOUND 48-80-INDUCED LETHALITY - SIMPLE TEST FOR INHIBITORS OF MAST CELL-MEDIATED SHOCK1978
- Allergy Induced Asthma with Ascaris Suum Administration to DogsThe Japanese Journal of Pharmacology, 1977
- Comparisons of Reaginic Antibodies from Three SpeciesThe Journal of Immunology, 1969